Financial Health Assessment: WANZL LIMITED

Companies House No: 01403566
Assessment Date: Based on latest available filings
Patient Status: Active, Private Limited Company

1. Financial Health Score: B (Provisional)

Explanation:
WANZL LIMITED receives a provisional B grade. The company shows strong external signs of health: it is actively trading, fully compliant with filing deadlines, has no insolvency proceedings, and has operated for over four decades. However, the actual financial statements were not provided in detail, so the grade is based on corporate health indicators and compliance markers rather than verified profitability, cash flow, or balance sheet strength. The "provisional" label reflects that the grade could rise to an A or fall to a C after reviewing the underlying accounts.

2. Key Vital Signs

Interpretation of Vital Signs:
The patient is breathing normally. There are no emergency signals, no overdue regulatory filings, and no public markers of insolvency. The company appears to be a well-established, mid-to-large sized wholesale business with a credible operating presence. The main "unknown" is the internal financial data — the equivalent of a blood test — which has not been disclosed in this assessment.

3. Diagnosis

Symptoms Analysis

What the numbers (and lack of numbers) reveal:

• No symptoms of acute distress: The company is not in liquidation, administration, or receivership. No winding-up petitions are visible. This is the corporate equivalent of a patient walking into the surgery with normal heart rate and blood pressure.
• Chronic stability: A 46-year trading history suggests the company has survived multiple economic cycles, including recessions, pandemics, and industry disruption. This is a strong constitutional indicator.
• Compliance health: Filing accounts and confirmation statements on time is a behavioural marker of good corporate governance. Late or missing filings are often the first visible symptom of financial trouble. Here, there are none.
• Capital buffer: £700,000 in share capital is a meaningful buffer. It suggests the company is not operating on a knife-edge of minimal capitalisation.
• Unknown underlying conditions: The absence of actual financial figures means we cannot assess:
• Profitability (is the company making money?)
• Liquidity (can it pay debts as they fall due?)
• Solvency (do liabilities exceed assets?)
• Working capital efficiency (are debtors and stock under control?)
• Gearing (how much debt is on the balance sheet?)
• Cash flow generation (is operating cash flow positive?)

These are the vital signs that would confirm the patient is not just alive, but genuinely fit.

Prognosis

• If underlying financials are consistent with the company's history and compliance record: The outlook is good. A stable, long-established wholesale business with strong capital and clean governance is well positioned.
• If underlying financials reveal hidden issues — such as declining margins, high debtors, or reliance on a single customer — the outlook could deteriorate quickly despite the clean external appearance.
• Next critical checkpoint: The next accounts (for the year ending 31 December 2025) will be due by 30 September 2027. However, the most recent filed accounts should be reviewed immediately to confirm the internal financial position.

Overall Diagnosis:
WANZL LIMITED presents as a generally healthy corporate patient with good external vital signs and no visible symptoms of distress. However, the diagnosis is incomplete without access to the full financial statements. This is like a doctor saying "the patient appears fit, but I need the blood test results before I can give a clean bill of health."

4. Recommendations

Based on this diagnostic review, I would prescribe the following:

1. Obtain and Review the Full Financial Statements

• The most recent filed accounts (year ended 31 December 2025) should be obtained from Companies House.
• Key metrics to check:
• Net assets / shareholders' funds — is the balance sheet solvent?
• Net current assets / working capital — can the business cover short-term liabilities?
• P&L reserve — are profits being retained or are losses eroding capital?
• Debt levels — is the company reliant on borrowing?

2. Monitor Working Capital Closely

• As a wholesale business (SIC 46900), cash flow is the lifeblood. Slow-paying debtors or excess stock can turn a profitable company into a cash-poor one very quickly.
• Recommend tracking debtor days, creditor days, and stock turnover on a monthly basis.

3. Review the PSC Register

• The data shows a "Persons with Significant Control statement" but no individual PSC names are listed. Ensure the PSC register is accurate and up to date, and that any changes are filed within 28 days.

4. Maintain Filing Discipline

• The company is currently fully compliant. Continue to file accounts and confirmation statements on time to preserve the clean regulatory record. Late filings would be an early warning sign to lenders and suppliers.

5. Stress-Test the Business

• Given the wholesale sector's exposure to economic cycles, conduct a simple stress test:
• What would happen if revenue fell 20%?
• Could the business still pay suppliers and staff?
• Is there access to emergency funding if needed?

6. If You Are a Supplier, Lender, or Investor

• Do not rely solely on this external data. Request the full accounts and, if material, a credit report or bank references before extending significant credit or investment.

Executive Summary

WANZL LIMITED is a long-established, active wholesale company with an excellent compliance record, a strong capital base, and no visible signs of financial distress. However, a full financial health assessment cannot be completed without reviewing the actual accounts, and the provisional grade of B reflects the absence of verified financial data. Overall, the company appears to be in good corporate health, but the underlying financial statements should be examined to confirm there are no hidden issues.